KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Idexx Laboratories (IDXX) Net Margin (2016 - 2025)

Idexx Laboratories (IDXX) has 17 years of Net Margin data on record, last reported at 22.76% in Q4 2025.

  • For Q4 2025, Net Margin rose 11.0% year-over-year to 22.76%; the TTM value through Dec 2025 reached 24.62%, up 184.0%, while the annual FY2025 figure was 24.62%, 184.0% up from the prior year.
  • Net Margin reached 22.76% in Q4 2025 per IDXX's latest filing, down from 24.85% in the prior quarter.
  • Across five years, Net Margin topped out at 26.5% in Q2 2025 and bottomed at 15.34% in Q2 2022.
  • Average Net Margin over 5 years is 22.76%, with a median of 23.18% recorded in 2022.
  • Peak YoY movement for Net Margin: skyrocketed 117031bps in 2021, then plummeted -910bps in 2022.
  • A 5-year view of Net Margin shows it stood at 20.32% in 2021, then rose by 2bps to 20.78% in 2022, then grew by 4bps to 21.58% in 2023, then increased by 5bps to 22.65% in 2024, then rose by 0bps to 22.76% in 2025.
  • Per Business Quant database, its latest 3 readings for Net Margin were 22.76% in Q4 2025, 24.85% in Q3 2025, and 26.5% in Q2 2025.